{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0067-6095",
      "generic_name": "ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL",
      "labeler_name": "Haleon US Holdings LLC",
      "brand_name": "THERAFLU POWERPODS NIGHTTIME SEVERE COLD",
      "brand_name_suffix": "POWERPODS NIGHTTIME SEVERE COLD",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "650 mg/1"
        },
        {
          "name": "DIPHENHYDRAMINE HYDROCHLORIDE",
          "strength": "25 mg/1"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "10 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0067-6095-01",
          "description": "8 POUCH in 1 CARTON (0067-6095-01)  / 1 POWDER, FOR SOLUTION in 1 POUCH (0067-6095-02)",
          "marketing_start_date": "20180728",
          "sample": false
        },
        {
          "package_ndc": "0067-6095-03",
          "description": "1 POUCH in 1 CARTON (0067-6095-03)  / 1 POWDER, FOR SOLUTION in 1 POUCH",
          "marketing_start_date": "20190120",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Haleon US Holdings LLC"
        ],
        "rxcui": [
          "1659960"
        ],
        "spl_set_id": [
          "39f9feef-4bf2-4f10-9fff-22bbb1d8a471"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "362O9ITL9D",
          "TC2D6JAD40",
          "04JA59TNSJ"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "POWDER, FOR SOLUTION",
      "spl_id": "102bd52f-def1-ca60-e063-6294a90a1d4d",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20180728",
      "product_id": "0067-6095_102bd52f-def1-ca60-e063-6294a90a1d4d",
      "application_number": "M012",
      "brand_name_base": "THERAFLU",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Histamine H1 Receptor Antagonists [MoA]",
        "Histamine-1 Receptor Antagonist [EPC]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}